Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1965 Jun;24(3):759–772. doi: 10.1111/j.1476-5381.1965.tb01632.x

Modification by drugs of the metabolism of 3,4-dihydroxyphenylethylamine, noradrenaline and 5-hydroxytryptamine in the brain

R Laverty, D F Sharman
PMCID: PMC1704029  PMID: 14340930

Full text

PDF
760

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHCROFT G. W., SHARMAN D. F. Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus. Br J Pharmacol Chemother. 1962 Aug;19:153–160. doi: 10.1111/j.1476-5381.1962.tb01436.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. AYD F. J., Jr Neuroleptics and extrapyramidal reactions in psychiatric patients. Rev Can Biol. 1961 Jun;20:451–459. [PubMed] [Google Scholar]
  3. BAIRD J. R., LEWIS J. J. Effects of drugs on noradrenaline and 3-hydroxytyramine (dopamine) levels and on the noradrenaline to dopamine ratio in the rat brain. Biochem Pharmacol. 1963 Jun;12:579–581. doi: 10.1016/0006-2952(63)90134-5. [DOI] [PubMed] [Google Scholar]
  4. BARBEAU A., SOURKES T. L. Some biochemical aspects of extrapyramidal diseases. Rev Can Biol. 1961 Jun;20:197–203. [PubMed] [Google Scholar]
  5. BERTLER A., CARLSSON A., ROSENGREN E. A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiol Scand. 1958 Dec 15;44(3-4):273–292. doi: 10.1111/j.1748-1716.1958.tb01627.x. [DOI] [PubMed] [Google Scholar]
  6. BRODIE B. A., SHORE P. A., PLETSCHER A. Serotonin-releasing activity limited to Rauwolfia alkaloids with tranquilizing action. Science. 1956 Jun 1;123(3205):992–993. doi: 10.1126/science.123.3205.992-a. [DOI] [PubMed] [Google Scholar]
  7. CARMAN J. B., COWAN W. M., POWELL T. P. THE ORGANIZATION OF CORTICO-STRIATE CONNEXIONSIN THE RABBIT. Brain. 1963 Sep;86:525–562. doi: 10.1093/brain/86.3.525. [DOI] [PubMed] [Google Scholar]
  8. CHO A. K., HASLETT W. L., JENDEN D. J. The identification of an active metabolite of tremorine. Biochem Biophys Res Commun. 1961 Jul 26;5:276–279. doi: 10.1016/0006-291x(61)90162-0. [DOI] [PubMed] [Google Scholar]
  9. COLE J. O., CLYDE D. J. Extrapyramidal side effects and clinical response to the phenothiazines. Rev Can Biol. 1961 Jun;20:565–574. [PubMed] [Google Scholar]
  10. LAVERTY R., SHARMAN D. F. THE ESTIMATION OF SMALL QUANTITIES OF 3,4-DIHYDROXYPHENYLETHYLAMINE IN TISSUES. Br J Pharmacol Chemother. 1965 Apr;24:538–548. doi: 10.1111/j.1476-5381.1965.tb01744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. LESLIE G. B., MAXWELL D. R. SOME PHARMACOLOGICAL PROPERTIES OF THIOPROPERAZINE AND THEIR MODIFICATION BY ANTI-PARKINSONIAN DRUGS. Br J Pharmacol Chemother. 1964 Apr;22:301–317. doi: 10.1111/j.1476-5381.1964.tb02035.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MAYNERT E. W., KLINGMAN G. I., KAJI H. K. Tolerance to morphine. II. Lack of effects on brain 5-hydroxytryptamine and gamma-aminobutyric acid. J Pharmacol Exp Ther. 1962 Mar;135:296–299. [PubMed] [Google Scholar]
  13. PAASONEN M. K., GIARMAN N. J. Brain levels of 5-hydroxytryptamine after various agents. Arch Int Pharmacodyn Ther. 1958 Mar 1;114(2):189–200. [PubMed] [Google Scholar]
  14. PAASONEN M. K., VOGT M. The effect of drugs on the amounts of substance P and 5-hydroxytryptamine in mammalian brain. J Physiol. 1956 Mar 28;131(3):617–626. doi: 10.1113/jphysiol.1956.sp005486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SHARMAN D. F. A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue. Br J Pharmacol Chemother. 1963 Feb;20:204–213. doi: 10.1111/j.1476-5381.1963.tb01310.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. SHARMAN D. F., VANOV S., VOGT M. Noradrenaline content in the heart and spleen of the mouse under normal conditions and after administration of some drugs. Br J Pharmacol Chemother. 1962 Dec;19:527–533. doi: 10.1111/j.1476-5381.1962.tb01458.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. UDENFRIEND S., ZALTZMAN-NIRENBERG P. NOREPINEPHRINE AND 3,4DIHYDROXYPHENETHYLAMINE TURNOVER IN GUINEA PIG BRAIN IN VIVO. Science. 1963 Oct 18;142(3590):394–396. doi: 10.1126/science.142.3590.394. [DOI] [PubMed] [Google Scholar]
  18. VOGT M. The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J Physiol. 1954 Mar 29;123(3):451–481. doi: 10.1113/jphysiol.1954.sp005064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. WEIL-MALHERBE H., BONE A. D. The chemical estimation of adrenaline-like substances in blood. Biochem J. 1952 Jun;51(3):311–318. doi: 10.1042/bj0510311. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES